Evidence map›Paper›PMID 38268532›Full record

ArticleEClinicalMedicine2024

Prevalence of chronic cough, its risk factors and population attributable risk in the Burden of Obstructive Lung Disease (BOLD) study: a multinational cross-sectional study.

Hazim Abozid, Jaymini Patel, Peter Burney, Sylvia Hartl, Robab Breyer-Kohansal, Kevin Mortimer, Asaad A Nafees, Mohammed Al Ghobain, Tobias Welte, Imed Harrabi and 27 more

Abstract read
In one paragraph

Article in EClinicalMedicine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

37 authors.

Hazim AbozidDepartment of Respiratory and Pulmonary Diseases, Clinic Penzing, Vienna Healthcare Group, Vienna, Austria.
Jaymini PatelNational Heart and Lung Institute, Imperial College London, London, UK.
Peter BurneyNational Heart and Lung Institute, Imperial College London, London, UK.
Sylvia HartlLudwig Boltzmann Institute for Lung Health, Vienna, Austria.
Robab Breyer-KohansalLudwig Boltzmann Institute for Lung Health, Vienna, Austria.
Kevin MortimerUniversity of Cambridge, Cambridge, UK.
Asaad A NafeesDepartment of Community Health Sciences, Aga Khan University, Karachi, Pakistan.
Mohammed Al GhobainKing Saud bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia.
Tobias WelteDepartment of Respiratory Medicine/Infectious Disease, Member of the German Centre for Lung Research, Hannover School of Medicine, Germany.
Imed HarrabiIbn El Jazzar Faculty of Medicine of Sousse, University of Sousse, Sousse, Tunisia.
Meriam DenguezliDepartment of Pneumology, Faculty of Medicine Annaba, University Badji Mokhtar of Annaba, Annaba, Algeria.
Li Cher LohRoyal College of Surgeons in Ireland and University College Dublin Malaysia Campus, Penang, Malaysia.
Abdul RashidRoyal College of Surgeons in Ireland and University College Dublin Malaysia Campus, Penang, Malaysia.
Thorarinn GislasonFaculty of Medicine, University of Iceland, Reykjavík, Iceland.
Cristina BarbaraInstituto de Saúde Ambiental, Faculdade de Medicina, Universidade de Lisboa, Lisbon, Portugal.
Joao CardosoPulmonology Department, Centro Hospitalar Universitário de Lisboa Central, Lisboa, Portugal.
Fatima RodriguesServiço de Pneumologia, Centro Hospitalar Universitário Lisboa Norte, Lisbon, Portugal.
Terence SeemungalFaculty of Medical Sciences, University of West Indies, St Augustine, Trinidad and Tobago.
Daniel ObasekiDepartment of Medicine, Obafemi Awolowo University, Ile-Ife, Nigeria.
Sanjay JuvekarVadu Rural Health Program, KEM Hospital Research Centre, Pune, India.
Stefanni Nonna ParaguasPhilippine College of Chest Physicians, Manila, Philippines.
Wan C TanUniversity of British Columbia Centre for Heart Lung Innovation, St Paul's Hospital, Vancouver, BC, Canada.
Frits M E FranssenMaastricht University Medical Centre, Maastricht, the Netherlands.
Filip MejzaCentre for Evidence Based Medicine, 2nd Department of Internal Medicine, Jagiellonian University Medical College, Kraków, Poland.
David ManninoUniversity of Kentucky, Lexington, KY, USA.
Christer JansonDepartment of Medical Sciences, Respiratory, Allergy and Sleep Research, Uppsala University, Uppsala, Sweden.
Hamid Hacene CherkaskiDepartment of Pneumology, Faculty of Medicine Annaba, University Badji Mokhtar of Annaba, Annaba, Algeria.
Mahesh Padukudru AnandDepartment of Respiratory Medicine, JSS Medical College, JSSAHER, Mysuru, India.
Hasan HafiziFaculty of Medicine, Tirana University Hospital "Shefqet Ndroqi", Tirana, Albania.
Sonia BuistOregon Health & Science University, Portland, USA.
Parvaiz A KoulDepartment of Pulmonary Medicine, Sheri Kashmir Institute of Medical Sciences, Srinagar, India.
Asma El SonyEpi-Lab, Khartoum, Sudan.
Marie-Kathrin BreyerDepartment of Respiratory and Pulmonary Diseases, Clinic Penzing, Vienna Healthcare Group, Vienna, Austria.
Otto C BurghuberLudwig Boltzmann Institute for Lung Health, Vienna, Austria.
Emiel F M WoutersLudwig Boltzmann Institute for Lung Health, Vienna, Austria.
Andre F S AmaralNational Heart and Lung Institute, Imperial College London, London, UK.
BOLD Collaborative Research Group

Funding

Wellcome Trust
6 · The paper itself

Abstract

Background: Chronic cough is a common respiratory symptom with an impact on daily activities and quality of life. Global prevalence data are scarce and derive mainly from European and Asian countries and studies with outcomes other than chronic cough. In this study, we aimed to estimate the prevalence of chronic cough across a large number of study sites as well as to identify its main risk factors using a standardised protocol and definition. Methods: We analysed cross-sectional data from 33,983 adults (≥40 years), recruited between Jan 2, 2003 and Dec 26, 2016, in 41 sites (34 countries) from the Burden of Obstructive Lung Disease (BOLD) study. We estimated the prevalence of chronic cough for each site accounting for sampling design. To identify risk factors, we conducted multivariable logistic regression analysis within each site and then pooled estimates using random-effects meta-analysis. We also calculated the population attributable risk (PAR) associated with each of the identifed risk factors. Findings: The prevalence of chronic cough varied from 3% in India (rural Pune) to 24% in the United States of America (Lexington,KY). Chronic cough was more common among females, both current and passive smokers, those working in a dusty job, those with a history of tuberculosis, those who were obese, those with a low level of education and those with hypertension or airflow limitation. The most influential risk factors were current smoking and working in a dusty job. Interpretation: Our findings suggested that the prevalence of chronic cough varies widely across sites in different world regions. Cigarette smoking and exposure to dust in the workplace are its major risk factors. Funding: Wellcome Trust.

Indexed as

Chronic coughEpidemiologyExcess riskGlobal health

Identifiers

PMID38268532
PMCPMC10807979

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.